A Single Cycle of Rituximab for the Treatment of Severe Pemphigus | NEJM
RA | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA) in Rheumatoid Arthritis
PV | RITUXAN® (rituximab) Safety Data
Extended infusion of rituximab combined with steroids is effective in inducing remission and reducing relapse in adult minimal change disease | BMC Nephrology | Full Text
GPA & MPA | RITUXAN® (rituximab) Safety on Follow Up Treatment
Rituxan side effects and how to avoid them - NiceRx
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy
immediate and long-term side effects of rituximab administration | Download Table
PV | RITUXAN® (rituximab) Safety Data
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial - The Lancet
Rituxan Side Effects - HRF
Rituximab Treatment in Nephrotic Syndrome ESPN ppt download
PV | Taking & Dosing RITUXAN® (rituximab)
Rituximab (Riximyo) Drug Information
Common indications for rituximab therapy Disease conditions Chronic... | Download Table
Rituximab (Rituxan) Drug Information
Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes - ScienceDirect
Rituximab | Uses, Dosage, Side Effects and Mechanism | Rituxan - YouTube
Acute infusion reactions associated with rituximab treatment | Download Table
Efficacy and safety of long-term repeated use of rituximab in pediatric patients with nephrotic syndrome | Pediatric Nephrology
The effects of Rituximab on Graves'orbitopathy: A retrospective study of 14 patients | Semantic Scholar
Chronic Lymphocytic Leukemia (CLL) Relapse | RITUXAN® (rituximab)
Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome
Frontiers | Rituximab Hypersensitivity: From Clinical Presentation to Management
RA | Safety Data & Possible Side Effects | RITUXAN® (rituximab)
Dosing Schedules | RITUXAN HYCELA for FL, DLCBL, CLL
Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019? | Haematologica
